Chemical Structure (Topiramate 8593 8594 8595 1)
Topiramate Tablet, Film Coated
Product Images NDC 0615-8593
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 0615-8593). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: Kaplan-meier Estimates Of Cumulative Rates For Time To First Seizure (Topiramate 8593 8594 8595 2)
Figure 2 (Topiramate 8593 8594 8595 3)
This text appears to be a comparison table showing the effectiveness of Topiramate, Placsbo, and their various dosages in a study based on the Change From Baseline to Double-Blind Phase in Average Monthly Rate. The table includes different dosage groups (50mg/day, 100mg/day, 200mg/day) and the number of participants in each group (N=). It also mentions statistical significance levels (*p<0.01, **p<0.001) for the study results.*
Principal Display Panel (Topiramate 8593 8594 8595 4)
This is a pharmaceutical label containing information about Topiramate tablets USP 25 mg, including lot numbers, expiration dates, manufacturer details (Aurobindo), and storage instructions. The tablets are intended for institutional use only and the usual dosage should be followed as per the package insert. It is essential to store the tablets at temperatures between 20 to 25°C (68° to 77°F) with excursions permitted. The trademark for the packaging belongs to Omnicare, Inc.*
Principal Display Panel (Topiramate 8593 8594 8595 5)
This is a detailed description of the Topiramate Tablet, containing 50 mg of USP (United States Pharmacopeia) grade Topiramate. The tablets are film-coated and come in a package intended for institutional use only. The storage instructions include keeping the tablets at temperatures between 20°C and 25°C (68°F to 77°F) with excursions permitted up to 30°C (86°F). It is essential to protect the tablets from moisture. The package includes multiple tablets in various batches and lots. The full prescribing information can be found in the package insert. This package is a trademark of Omnicare, Inc.*
Principal Display Panel (Topiramate 8593 8594 8595 6)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
